Lovastatin inhibits bone marrow-derived dendritic cell maturation and upregulates proinflammatory cytokine production
- 1 May 2003
- journal article
- Published by Elsevier in Cellular Immunology
- Vol. 223 (1), 52-62
- https://doi.org/10.1016/s0008-8749(03)00148-5
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Statins as a newly recognized type of immunomodulatorNature Medicine, 2000
- Current Perspectives on StatinsCirculation, 2000
- Reduction of Platelet Activity Markers in Type II Hypercholesterolemic Patients by a HMG-CoA-Reductase InhibitorThrombosis Research, 1999
- An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrowJournal of Immunological Methods, 1999
- Dendritic cells and the control of immunityNature, 1998
- Cholesterol Lowering With Statin Drugs, Risk of Stroke, and Total MortalityJAMA, 1997
- Origin, maturation and antigen presenting function of dendritic cellsCurrent Opinion in Immunology, 1997
- Effect of Pravastatin on Outcomes after Cardiac TransplantationNew England Journal of Medicine, 1995
- Cell cycle-specific effects of lovastatin.Proceedings of the National Academy of Sciences, 1991
- Immune response in the mutant diabetic C57BL/Ks-dt+ mouse. Discrepancies between in vitro and in vivo immunological assays.Journal of Clinical Investigation, 1978